MMMuhammad Sohail S. Mirza

Muhammad Sohail S. Mirza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Muhammad Sohail S. Mirza has a total of 89 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of a Gluten-Free Diet on Gastrointestinal Symptoms and Quality of Life in Non-celiac Gluten-Related Disorders: A Systematic Review and Meta-Analysis

    by Shabnam A Memon, Ghazala S Virk, Brahmaiahchari Rangachari, Harshni Kalimuthu, Ishani Jayantibhai Trada, Muhammad Sohail S Mirza, Ahmed Mubarak

    Non-celiac gluten sensitivity (NCGS) is a gastrointestinal and extraintestinal condition characterized by symptoms triggered by the ingestion of gluten, but it does not involve celiac disease (CD) or an allergic reaction to wheat. This meta-analysis and systematic evaluation were intended to determine the impact of a gluten-free diet (GFD) on gastrointestinal symptom reduction and quality of life (QoL) in NCGS patients. We filtered studies published from 2010 to 2025, focusing on randomized controlled trials and observational studies. The findings showed that GFD significantly promoted gastrointestinal signs and symptoms and QoL, and the pooled effect was 0.88 (95% CI = 0.20-1.55), which showed a marginal effect. Nonetheless, significant heterogeneity was observed (I² = 97.77%), suggesting that variability in effects may be attributed to differences in study design, participant characteristics, and adherence to the diet. Subgroup analysis suggested a larger pooled effect among participants with NCGS (pooled effect size = 0.93) than among participants with CD or less clearly defined gluten-related sensitivity (pooled effect size = 0.74). However, high heterogeneity within the NCGS subgroup indicates the need for further well-designed studies. The evaluation indicates that adherence and baseline symptom severity are key factors influencing the efficacy of diet. Publication bias was not identified as a major concern, as suggested by the relatively symmetrical funnel plot and the non-significant results of the statistical tests. Overall, this meta-analysis suggests that a GFD may be a useful intervention for patients with NCGS; however, individualized dietary management is needed because responses may vary across patients.

  • Open Access

    Efficacy of Fecal Microbiota Transplantation (FMT) Versus Standard Antibiotic Therapy in Recurrent Clostridioides difficile (CDI/rCDI) Infection: A Systematic Review and Meta-Analysis

    by Rubela Ray, Sarah A Hack, Avreen Kaur Vij, Khadijat Ishola Gbenla, Suman Khatri, Dinesh Aravind Rongali, Ayesha Khalid, Ayesha Anjum, Ruhab S. Fancy, Muhammad Sohail S. Mirza

    Repeated Clostridioides difficile infection (rCDI) is a hard clinical problem because normal antibiotic treatment usually doesn't stop relapses. Fecal microbiota transplantation (FMT) has come up as another way to try to fix the gut's microbial balance. This review and study looked at how well FMT works and how safe it is compared to normal antibiotic treatment for rCDI. We searched PubMed, Embase, and the Cochrane Library up to December 2023 to find trials and studies. We used a model to calculate risk ratios, and we also looked at subgroups based on how FMT was given and the patient's age. After checking fifteen studies with 1,452 patients, we found that FMT worked better than antibiotics [relative risk (RR) = 1.85, 95% confidence interval (CI): 1.62-2.11, p < 0.001], with recurrence rates of 16% versus 42%. Subgroup checks showed that FMT worked well no matter how it was given, whether by colonoscopy, tube, or capsules. Side effects were usually small and about the same for both FMT and antibiotics. In conclusion, FMT is safer and does a better job than normal antibiotics for rCDI and should be thought of as the main treatment after the first time the infection comes back.


  • Open Access

    Impact of E-cigarette Use on Cardiovascular Risk Markers in Elderly Former Smokers: A Systematic Review and Meta-Analysis

    by Anil Reddy Padi, Rutvij Patel, Maheshwar Dumpala, Ayesha Anjum, Israr Ahmed, Venkata Sai Krishna Reddy Dronadula, Zain Bin Saeed, Muhammad Sohail S. Mirza, Ramya Reddy Jonnala

    E-cigarette (EC) use has been associated with several chronic cardiovascular effects. These include arterial stiffness, endothelial dysfunction, and increased oxidative stress. Despite the fact that the use of ECs has been welcomed as potentially less dangerous than alternatives compared to the smoking of conventional cigarettes, the impact that the utilization of ECs has on cardiovascular condition is an issue that is open to a controversial debate. The purpose of this systematic review and meta-analysis was to ascertain the cardiovascular risk of EC smoking as related to that of nonsmoking and conventional smoking. The exhaustive search was conducted on a variety of databases (Scopus, PubMed, Web of Science, and Google Scholar) for identifying cross-sectional studies, randomized controlled trials, and observational cohort studies that were published between 2015 and 2025. Pooled analysis was performed on the data, and the correlation coefficient was estimated through a model of random effects. The heterogeneity was assessed through the publication bias, and the I² statistic was tackled through funnel plots and Egger’s test. The overall analysis demonstrated that EC smoking was related to higher vascular stiffness and oxidative stress, although to a lesser degree compared to conventional cigarette smoking. The total effect size indicated a positive but moderate relationship (r = 0.60, 95% CI: 0.45-0.81) between EC smoking and cardiovascular risks. Although the results were encouraging, there was substantial heterogeneity (I² = 99.99%), showing variation in findings. This implies that future research is obligatory to explicate appropriate long-term cardiovascular consequences of EC consumption, especially among dual users.


  • Open Access

    Association Between Polypharmacy and Cardiovascular Outcomes in Frail Elderly Patients: Systematic Review and Meta-Analysis

    by Ghazala S. Virk, Ahsan Munir, Wala Alim, Usman Zia, Layla Hago Mustafa Ali, Samah Mohammed, Fnu Deepak, Mahdi Ogeil, Dhruv Indiresh, Marium Abid, et al.

    Polypharmacy, which is the simultaneous use of five or more pharmacological agents, is still prevalent in old people, particularly frail ones with numerous comorbidities. This current systematic review and metaanalysis aimed to explain the effects of polypharmacy on the cardiovascular outcomes of this vulnerable group. The search was conducted in PubMed, Scopus, Cochrane Library, and Google Scholar, including all studies that were published between 2020-2025. The focus of the inquiry was on the consequences of polypharmacy to cardiovascular health, major adverse cardiovascular events (MACE), cardiovascular mortality, heart failure hospitalizations, and functional deterioration. Randomized controlled trials (RCTs) and cohort studies were both included. The meta-analysis involved the use of a random-effects model to determine the pooled effect size. The above synthesis showed a significant relationship between polypharmacy and adverse cardiovascular outcomes, and the effect size was 0.93 (95% CI: 0.48-139). These results suggest that polypharmacy significantly increases the chances of developing cardiovascular complications in frail elderly patients. There was a very large heterogeneity, and I2 was 96.30%. It is believed that the possible causes of this heterogeneity comprise variations in study design, characteristics of participants, and outcomes. Risk-of-bias evaluation highlighted significant disparity among studies, with certain studies characterized as having low risk of bias and others rated as having moderate-to-high risk. There was no publication bias, as testified by the symmetrical funnel plot, and no statistical significance of the Egger test. Nevertheless, in spite of these weaknesses, the results of the research point to the high adverse outcome of polypharmacy on cardiovascular measures in frail elderly adults. Thus, it underlines the necessity of medication review and deprescribing interventions in this patient group.


  • Open Access

    Effectiveness of Telecardiology Interventions on Reducing Hospital Readmissions in Elderly Heart Failure: Systematic Review and Meta-Analysis

    by Ghazala S. Virk, Sarah Hack, Chandini Gundala, Tanzeela Saeed, Deep Patel, Sai Prashanthi Varakala, Yukesh Karki, Venkata Avinash Ugripelli, Marium Abid, Binish Essani, et al.

    Heart failure becomes a chronic condition when the heart cannot pump blood properly. The cycle then repeats, hospitalizations are recorded for acute heart failure; interventions are sought to prevent further hospitalizations. Telecardiology interventions, such as remote monitoring and teleconsultation, were therefore proposed as a means to ramp up heart failure management and diminish the incidence of readmission. The systematic review and meta-analysis aimed to evaluate the impact of telecardiology interventions on two levels of outcome-reduction of hospital readmissions. An elaborate search was carried out in renowned bibliographic databases, namely, PubMed, Google Scholar, Cochrane Library, and Scopus, for randomized controlled trials (RCTs) and cohort studies published between 2000 and 2025. The included studies evaluated telemedicine interventions, which included mobile health applications, nurse-led telemonitoring, and teleconsultations. The primary outcome was the rate of hospital readmission; the secondary outcome measures included quality of life, patient satisfaction, and functional capacity. Meta-analysis on pooled data was done using a random-effects model for effect size estimation. Overall effect size was found to be 0.71 (95% CI: 0.31-1.11). It suggested a moderate reduction in readmissions with telecardiology interventions, though high heterogeneity (I² = 91.95%) was seen, which is due to differences in the designs of included studies, interventions, and populations. There was no significant publication bias as measured by the funnel plot and Egger's test. Risk of Bias showed variability across studies; some were low risk, and others moderate to high risk. Despite these limitations, results indicate that telecardiology may be effective in reducing hospital readmissions, although future research will be needed to better refine intervention models and patient-specific approaches.

  • Open Access

    The Effectiveness of Cardiac Rehabilitation Programs in Improving Cardiovascular Outcomes: Systematic Review and Meta-Analysis

    by Arhum Mahmood, Rubela Ray, Fatima Haque, Jahnavi Akkaldevi, Mohd Diya Masmoum, Mohammad S. Hassan, Binish Essani, Tooba Anjum, Muhammad Sohail S. Mirza, Shaikh Shams Tabrez Bin Salam

    Cardiovascular diseases (CVDs) are some of the most common conditions and the major contributors to death and disability globally, hence the need for proper secondary prevention interventions. Cardiac rehabilitation (CR) programs have been recognized as an essential component in the treatment of CVDs with the goal of decreasing the risk of new cardiovascular events and improving the quality of life. This systematic review and meta-analysis sought to determine the impact of CR as a form of CVD treatment on mortality, morbidity, functional capacity, and quality of life amongst the patient population. The search resulted in 12 studies that fulfilled the inclusion criteria, which included both randomized controlled trials as well as cohort studies. The meta-analysis, therefore, showed that the CR program is effective in reducing all-cause mortality (RR=0 74, 95% CI: 0.62-0. Favorable effects of intervention regarding participation measures were found in the International Classification of Functioning, Disability and Health (ICF) domains of body functions (pool standardized mean differences (SMD)= 0.55, 95% CI: 0.43-0.68). The results confirm the significance of CR programs as an essential element of secondary prevention of CVDs, stressing the ability of CR to lower mortality rates and improve patients' functional status. Despite this, the implementation of CR programs continues to be suboptimal globally for various healthcare facilities; hence the requirement for interventions to ensure that more patients incorporate the protocols and adapt uniform CR protocols.


  • Open Access

    Breaking the Antibiotic Habit: Shorter Treatments for Complicated Appendicitis

    by Ayman Nadeem, Sandra Abdelmessih, Dinesh K. Eetala, Jagadeeswar R. Peddapati, Ashritha Vanakuri, Syed Muhammad Rehman Shah, Kashif Uddin Ahmed, Mohammad Z. Natt, Fnu Fatima, Muhammad Sohail S. Mirza

    Background: Patients with acute complicated appendicitis, including gangrenous or perforated appendicitis and/or the presence of an abscess formation, usually require surgery followed by antibiotics. The optimal duration of antibiotic therapy for those infections is debatable; prolonged courses are practiced at other institutions. Objectives: We undertook this systematic review and comparison to assess the efficacy of various durations of postoperative antibiotic therapy on patients healing from complicated acute appendicitis. The endpoint was defined as overall infections, length-of-sickness hospitalization (LOS), and readmissions in randomizing-controlled scan trials that tested different periods for which a patient received antibiotics after surgery. Methods: A comprehensive search included MEDLINE, Cochrane Library, Web of Science, Embase, PubMed, and Google Scholar. We included studies with randomized controlled trials, cohort studies, and cohort and observational studies that compared various durations of postoperative antibiotics among adults or children suffering from complicated appendicitis. Results: Data was extracted and analyzed for infection rates, LOS, and readmission outcomes. Results: We included 13 studies with 4,675 participants in the meta-analysis. The meta-analysis found that short-term antibiotic therapy (≤5 days) is as effective as longer courses (> five days) in the prevention of postoperative infections. Patients in both the short- and long-term groups experienced similar rates of surgical site infections, intra-abdominal abscesses, and new-onset sepsis. Short-term therapy was also linked to a shorter LOS and comparable readmission rates.

  • Open Access

    The Effectiveness of Exercise in Reducing Cardiovascular Risk Factors Among Adults: A Systematic Review and Meta-Analysis

    by Mohd Diya Masmoum, Soha Khan, Waqas A. Usmani, Raheel Chaudhry, Rubela Ray, Arhum Mahmood, Maheen Afzal, Muhammad Sohail S. Mirza

    Cardiovascular disease (CVD) remains one of the major causes of sickness and death in the world. However, lifestyle modifications, such as exercise, can significantly reduce the risk of this disease. This study aimed to assess the effectiveness of various forms of physical activity in reducing CVD risk factors among adults. A comprehensive search of the databases PubMed, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Cochrane Central Register of Controlled Trials (CENTRAL), and Excerpta Medica Database (EMBASE) databases was conducted between January 1, 2014, and May 31, 2024, as per Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Randomized controlled trials (RCTs), cohort studies, and observational studies on the impact of aerobic, resistance, or combined training on cardiovascular risk factors in adults (≥18 years) were considered for inclusion. Data relating to primary outcomes, including stroke and myocardial infarction rates, BP, cholesterol levels, and BMI were collected. The Cochrane risk-of-bias tool and the Methodological Index for Non-Randomized Studies (MINORS) checklist were used for quality and bias assessment. Meta-analyses were performed using the RevMan software, with heterogeneity evaluated by I² statistics; 17 studies, including 11 RCTs and six cohort studies, met the inclusion criteria. There was a significant reduction in the mean systolic BP (SBP) by 3.32 mmHg [95% confidence interval (CI): 0.85-5.78 mmHg; p0.0001], although there was substantial heterogeneity in effect size across the studies (I² = 98%). Different types of physical activity (i.e., aerobic, resistance, or combined exercise) can effectively reduce key cardiovascular risk factors, including BP, cholesterol levels, and BMI values. Regular physical activity is still regarded as the most effective preventive measure against CVD, despite inconsistencies in research findings. Future studies should aim to identify optimal exercise programs and their long-term effects on diverse populations.


  • Open Access

    Impact of Omega-3 Fatty Acids on Cardiovascular Disease Prevention: an updated Meta-analysis of RCTs

    by S. Rahman, Waqas A. Usmani, Uzma Nureen, Ashraf Ullah, Mohd Diya Masmoum, Zaghum Abbas, Raneem Masmoum, Surya A. Palasani, Ali Noor, Muhammad Sohail S. Mirza

    Background: Omega-3 fatty acids have been extensively studied for their potential role in cardiovascular disease (CVD) prevention. This meta-analysis aims to provide an updated synthesis of data from randomized controlled trials (RCTs) to assess the efficacy of omega-3 supplementation in reducing cardiovascular risk. Methods: We conducted a meta-analysis of 17 RCTs involving 82,592 patients. The primary outcomes assessed were changes in triglyceride and LDL cholesterol levels, the incidence of major cardiovascular events (MACE), and cardiac mortalities. Statistical analyses were performed using a random-effects model. Results: Omega-3 supplementation resulted in a significant reduction in triglyceride levels by an average of 4.41 mg/dL (95% CI: -10.16 to 1.88) and a modest decrease in LDL levels by 0.70 mg/dL (95% CI: -2.12 to 0.72). Additionally, omega-3 fatty acids were associated with a 10% reduction in the risk of major cardiovascular events (RR: 0.90, 95% CI: 0.82 to 0.99) and a 35% reduction in cardiac mortalities (RR: 0.65, 95% CI: 0.44 to 0.95). Conclusion: This meta-analysis supports the use of omega-3 fatty acids as a preventive strategy in cardiovascular care, demonstrating significant benefits in lowering triglyceride levels, reducing major cardiovascular events, and decreasing cardiac mortalities.


  • Open Access

    Comparative Efficacy of Anti-tumor Necrosis Factor (TNF) Therapy in Inducing and Maintaining Remission from Crohn's Disease: A Systematic Review and Meta-analysis

    by Muhammad Sohail S. Mirza, Maria Khan, S. Rahman, Ayman Nadeem, Goutham R. Anugu, Mohd Diya Masmoum, Zainab Hameed, Muhammad H. Khawar, Muzafar Mansoor

    Background: Anti-TNF agents have emerged not only as inducers of remission but have also shown clinical efficacy in the maintenance of remission in patients suffering from Inflammatory Bowel Disease. However, there is limited quantitative evidence of their effectiveness in Crohn’s Disease. Aim: The current study aims to investigate the relative efficacy of anti-TNF agents in inducing and maintaining remission in Crohn’s Disease, by systematically evaluating efficacy outcomes, such as CDAI, SES-CD, and TEAEs. Methods: A number of digital databases were searched to retrieve relevant literature. This included PubMed, Google Scholar, Cochrane, ClinicalTrials.gov. The PICOS framework was used to systematically select the data. We used the PRISMA framework to synthesize and report the relevant data. Results: A total of 10 randomized control trials were included in the final sample. Among the anti-TNF agents, adalimumab and infliximab were most frequently used for disease control. Anti-TNF drugs were positively associated with clinical remission OR= 1.31 (95% CI (0.69, 2.10)), p50% reduction in endoscopic lesions), 1.65 (95% CI (1.44, 1.87)), pConclusion: Infliximab and adalimumab should be taken into consideration as first-line alternatives for maintaining remission in Crohn's disease due to their better efficacy and set-up safety profiles.